Biologics
-
Busting the Biologics Myth: Why Steroids, Not Advanced IBD Drugs, Raise Your Risk of Winter Bugs
Do advanced IBD drugs make you a target for winter colds and flu? A three-year clinical…
-
From Hospital Drips to Home Pens: Making the Switch to Under-the-Skin IBD Medicine Easier
Is it time to ditch the hospital drip? A new study evaluates the “access process” for…
-
Why Your Crohn’s or Colitis Medicine Needs a Safety ‘Lookout’
A major 2026 review warns of “paradoxical autoimmunity” in IBD patients using Anti-TNF biologics. Learn why…
-
New Study Reassures Patients about JAK Inhibitor Safety
A massive real-world study of US patients reveals that the UC pill tofacitinib is just as…
-
The ‘Postcode Lottery’: How Where You Live Affects Your IBD Care
A 14-year study of the Brazilian healthcare system reveals how income inequality and local development affect…
-
The Trillion-Dollar Medicine Cabinet: The Future of Your Treatment
U.S. drug spending is nearing $1 trillion, driven by a new wave of “specialty therapies.” While…
IBD Science for Patients 